Matches 1 - 21 out of 21


Match Document Document Title
DE102018107224A1 Peptides and combinations of peptides of non-canonical origin for use in immunotherapy against various cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic procedures. In particular, the present invention relates to the immunotherapy of cancer....
DE102016100039A1 Α6 integrin binding DNA aptamer  
The invention relates to a DNA aptamer which specifically binds α6 integrin. The object of the present invention is to provide means by means of which, for example, cancer treatment can be...
DE102007041476B4 Aptamers that bind to a target molecule involved in hemostasis  
Aptamer which binds to a target molecule involved in haemostasis, said aptamer being a thrombin-binding fusion aptamer comprising at least two aptamers binding to thrombin and at least one linker,...
DE102013112915A1 DNA aptamers that bind E- and P-selectins specifically  
The invention relates to aptamers that E- and P-selectins bind specifically. Object of the present invention is to provide means by which pathological conditions in which the adhesion of cells to...
DE102013204057A1 Fluoroquinolone specific aptamers  
The invention relates to aptamers that bind to one or more compounds from the group of fluoroquinolones, uses of aptamers as well as methods for the detection and enrichment of compounds from the...
DE102011006610B3 Aptamers that are specific for immunoglobulin binding cell wall proteins  
The invention relates to an aptamer that containing of protein A, G or L, Protein A, G or L substances and containing at Protein A, G or L microorganisms, in particular Staphylococcus aureus,...
DE102011006612B3 Aminoglycoside specific aptamers  
The invention relates to aptamers that bind to one or more compounds from the group of aminoglycosides, uses the aptamers and methods for detection and enrichment of compounds from the group of...
DE102010038842A1 New aptamer that specifically binds to human tau protein or its fragment, useful e.g. in vitro for isolating, purifying and/or detecting tau protein, and to treat cerebral infarction, pick disease and/or progressive supranuclear palsy  
Aptamer that specifically binds to human tau protein or its fragment, is new. Independent claims are included for: (1) kit comprising the aptamer; (2) a method for the purification of human tau...
DE102007041476A1 Aptamers that bind to a party to the hemostasis target molecule  
The Invention relates to an aptamer that binds to an haemostasis participating target molecule binds with the aptamer an aptamer is that binds to activated protein C, wherein the aptamer with a...
DE102007011702A1 Aptamer-based reagents  
The Invention relates to an aptamer-based reagent comprising at least a party to a haemostasis target molecule, with procoagulant, proaggregatorischer and / or activity profibrinolytischer binding...
DE102006026191A1 Device useful for isolating mesenchymal stem cells from biological tissues or fluids is coated with an aptamer that mediates binding of such cells  
Device with a surface coming into contact with a biological tissue or fluid has at least part of this surface coated with an aptamer that mediates binding of mesenchymal stem cells. Independent...
DE102004021707A1 A process for the isolation of specific molecules that bind with high selectivity to selected target molecules  
The This invention relates to a process for isolating specific molecules highly selective to selected target molecules tie. In particular, by displacement with a specific Competitor binding...
DE10393473T5 Trap tagging: a novel method for the identification and purification of RNA-protein complexes  
process for cleaning a formed in vitro RNA-protein complex comprising: (a) Providing an RNA-fusion molecule comprising a target RNA sequence and at least two different RNA markers, at least an RNA...
DE10358407A1 Antiapoptorisch effective aptamers (for the treatment of cardiovascular diseases)  
The present invention relates to anti-apoptotic effective aptamers. The corresponding sequences are shown. Possible therapeutic and diagnostic Uses are described, including atherosclerosis,...
DE10349441A1 Selecting nucleic acid that binds target molecules, useful potentially as therapeutic agents, by screening short sequences with two fixed regions flanking a random region  
Selecting a nucleic acid (I), especially an aptamer, that binds a target molecule (II), is new. Selecting a nucleic acid (I), especially an aptamer, that binds a target molecule (II) comprises:...
DE10258924A1 coated with the adhesion of biological material mediating substances device  
The invention relates to devices with at least one with tissues and / or fluids of the human or animal body by coming into contact surface. These surfaces are at least partially coated with...
DE10251246A1 New antagonists of calcitonin gene-related peptide or amylin, useful for treating or preventing e.g. migraine or inflammation, are specific binding nucleic acids  
An antagonist (I) of CGRP (calcitonin gene-related peptide), especially a nucleic acid, preferably one that binds to CGRP, is new. Independent claims are also included for: (1) antagonist (Ia) of...
DE10220188A1 New antagonists of calcitonin gene-related peptide or amylin, useful for treating or preventing e.g. migraine or inflammation, are specific binding nucleic acids  
An antagonist (I) of CGRP (calcitonin gene-related peptide), especially a nucleic acid, preferably one that binds to CGRP, is new. Independent claims are also included for: (1) antagonist (Ia) of...
DE10116829A1 Neuropeptide binding nucleic acids  
The present invention relates to a neuropeptide Y binding nucleic acid and the use thereof.
DE19916417A1 New amyloid-specific aptamer, useful for diagnosis and/or treatment of e.g. Alzheimer's disease, is stabilized against nucleases  
Amyloid-specific aptamer (I) that is stabilized against nucleic acid-degrading enzymes, and its alleles and/or derivatives, is new. An Independent claim is also included for a method of preparing...
DE19825395C1 New antiviral RNA that binds specifically to a picorna virus protein, for preventing rhinovirus, polio and Coxsackie virus infections  
Antiviral RNA (I) binds specifically to a peptide (A) or its variants with one or more amino acid deletions, substitutions or additions. (A) has formula (F1): PPGAPNPKEWDDYTWQSASC (F1) An...

Matches 1 - 21 out of 21